Industry Research Reports
Home > Reports > Pharma & Healthcare > Crude Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Crude Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Crude Heparin Market Size(US$)
CAGR 2025-2031
5.1%
Market Size,2031
USD 5,148
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 3,809 million
Market Forecast in 2031(Value)
US$ 5,148 million
CAGR
5.1%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Crude Heparin was estimated to be worth US$ 3640 million in 2024 and is forecast to a readjusted size of US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Global key players of crude heparin include Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend and Hebei Changshan Biochemical. The top five players hold a share about 46%. China is the largest market, which has a share about 56%, followed by North America and Europe, with share 19% and 18%, separately. In terms of product type, Pig Intestine Mucosa Heparin plays an important role with a share over 99%. In terms of application, LMWH holds an important share, with a share of 91%.
This report aims to provide a comprehensive presentation of the global market for Crude Heparin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Crude Heparin by region & country, by Type, and by Application.
The Crude Heparin market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Crude Heparin.
Market Segmentation
By Company
- Bioiberica
- Shenzhen Hepalink
- Sanofi
- Nanjing King-friend
- Fengrun Biological Technology
- Aspen Oss
- Hebei Changshan Biochemical
- Changzhou Qianhong
- Hepac (Darling Ingredients)
- Huaian MDC Pharmaceutical
- Yantai Dongcheng Biochemicals
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Pig Intestine Mucosa Heparin
- Bovine Heparin and Others
Segment by Application
- UFH
- LMWH
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Crude Heparin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Crude Heparin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Crude Heparin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYResearch's Strengths
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Market Overview
1.1 Crude Heparin Product Introduction
1.2 Global Crude Heparin Market Size Forecast
1.2.1 Global Crude Heparin Sales Value (2020-2031)
1.2.2 Global Crude Heparin Sales Volume (2020-2031)
1.2.3 Global Crude Heparin Sales Price (2020-2031)
1.3 Crude Heparin Market Trends & Drivers
1.3.1 Crude Heparin Industry Trends
1.3.2 Crude Heparin Market Drivers & Opportunity
1.3.3 Crude Heparin Market Challenges
1.3.4 Crude Heparin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Crude Heparin Players Revenue Ranking (2024)
2.2 Global Crude Heparin Revenue by Company (2020-2025)
2.3 Global Crude Heparin Players Sales Volume Ranking (2024)
2.4 Global Crude Heparin Sales Volume by Company Players (2020-2025)
2.5 Global Crude Heparin Average Price by Company (2020-2025)
2.6 Key Manufacturers Crude Heparin Manufacturing Base and Headquarters
2.7 Key Manufacturers Crude Heparin Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Crude Heparin
2.9 Crude Heparin Market Competitive Analysis
2.9.1 Crude Heparin Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Crude Heparin Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crude Heparin as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Pig Intestine Mucosa Heparin
3.1.2 Bovine Heparin and Others
3.2 Global Crude Heparin Sales Value by Type
3.2.1 Global Crude Heparin Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Crude Heparin Sales Value, by Type (2020-2031)
3.2.3 Global Crude Heparin Sales Value, by Type (%) (2020-2031)
3.3 Global Crude Heparin Sales Volume by Type
3.3.1 Global Crude Heparin Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Crude Heparin Sales Volume, by Type (2020-2031)
3.3.3 Global Crude Heparin Sales Volume, by Type (%) (2020-2031)
3.4 Global Crude Heparin Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 UFH
4.1.2 LMWH
4.2 Global Crude Heparin Sales Value by Application
4.2.1 Global Crude Heparin Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Crude Heparin Sales Value, by Application (2020-2031)
4.2.3 Global Crude Heparin Sales Value, by Application (%) (2020-2031)
4.3 Global Crude Heparin Sales Volume by Application
4.3.1 Global Crude Heparin Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Crude Heparin Sales Volume, by Application (2020-2031)
4.3.3 Global Crude Heparin Sales Volume, by Application (%) (2020-2031)
4.4 Global Crude Heparin Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Crude Heparin Sales Value by Region
5.1.1 Global Crude Heparin Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Crude Heparin Sales Value by Region (2020-2025)
5.1.3 Global Crude Heparin Sales Value by Region (2026-2031)
5.1.4 Global Crude Heparin Sales Value by Region (%), (2020-2031)
5.2 Global Crude Heparin Sales Volume by Region
5.2.1 Global Crude Heparin Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Crude Heparin Sales Volume by Region (2020-2025)
5.2.3 Global Crude Heparin Sales Volume by Region (2026-2031)
5.2.4 Global Crude Heparin Sales Volume by Region (%), (2020-2031)
5.3 Global Crude Heparin Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Crude Heparin Sales Value, 2020-2031
5.4.2 North America Crude Heparin Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Crude Heparin Sales Value, 2020-2031
5.5.2 Europe Crude Heparin Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Crude Heparin Sales Value, 2020-2031
5.6.2 Asia Pacific Crude Heparin Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Crude Heparin Sales Value, 2020-2031
5.7.2 South America Crude Heparin Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Crude Heparin Sales Value, 2020-2031
5.8.2 Middle East & Africa Crude Heparin Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Crude Heparin Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Crude Heparin Sales Value
6.2.1 Key Countries/Regions Crude Heparin Sales Value, 2020-2031
6.2.2 Key Countries/Regions Crude Heparin Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Crude Heparin Sales Value, 2020-2031
6.3.2 United States Crude Heparin Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Crude Heparin Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Crude Heparin Sales Value, 2020-2031
6.4.2 Europe Crude Heparin Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Crude Heparin Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Crude Heparin Sales Value, 2020-2031
6.5.2 China Crude Heparin Sales Value by Type (%), 2024 VS 2031
6.5.3 China Crude Heparin Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Crude Heparin Sales Value, 2020-2031
6.6.2 Japan Crude Heparin Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Crude Heparin Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Crude Heparin Sales Value, 2020-2031
6.7.2 South Korea Crude Heparin Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Crude Heparin Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Crude Heparin Sales Value, 2020-2031
6.8.2 Southeast Asia Crude Heparin Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Crude Heparin Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Crude Heparin Sales Value, 2020-2031
6.9.2 India Crude Heparin Sales Value by Type (%), 2024 VS 2031
6.9.3 India Crude Heparin Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Bioiberica
7.1.1 Bioiberica Company Information
7.1.2 Bioiberica Introduction and Business Overview
7.1.3 Bioiberica Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Bioiberica Crude Heparin Product Offerings
7.1.5 Bioiberica Recent Development
7.2 Shenzhen Hepalink
7.2.1 Shenzhen Hepalink Company Information
7.2.2 Shenzhen Hepalink Introduction and Business Overview
7.2.3 Shenzhen Hepalink Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Shenzhen Hepalink Crude Heparin Product Offerings
7.2.5 Shenzhen Hepalink Recent Development
7.3 Sanofi
7.3.1 Sanofi Company Information
7.3.2 Sanofi Introduction and Business Overview
7.3.3 Sanofi Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Sanofi Crude Heparin Product Offerings
7.3.5 Sanofi Recent Development
7.4 Nanjing King-friend
7.4.1 Nanjing King-friend Company Information
7.4.2 Nanjing King-friend Introduction and Business Overview
7.4.3 Nanjing King-friend Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Nanjing King-friend Crude Heparin Product Offerings
7.4.5 Nanjing King-friend Recent Development
7.5 Fengrun Biological Technology
7.5.1 Fengrun Biological Technology Company Information
7.5.2 Fengrun Biological Technology Introduction and Business Overview
7.5.3 Fengrun Biological Technology Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Fengrun Biological Technology Crude Heparin Product Offerings
7.5.5 Fengrun Biological Technology Recent Development
7.6 Aspen Oss
7.6.1 Aspen Oss Company Information
7.6.2 Aspen Oss Introduction and Business Overview
7.6.3 Aspen Oss Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Aspen Oss Crude Heparin Product Offerings
7.6.5 Aspen Oss Recent Development
7.7 Hebei Changshan Biochemical
7.7.1 Hebei Changshan Biochemical Company Information
7.7.2 Hebei Changshan Biochemical Introduction and Business Overview
7.7.3 Hebei Changshan Biochemical Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Hebei Changshan Biochemical Crude Heparin Product Offerings
7.7.5 Hebei Changshan Biochemical Recent Development
7.8 Changzhou Qianhong
7.8.1 Changzhou Qianhong Company Information
7.8.2 Changzhou Qianhong Introduction and Business Overview
7.8.3 Changzhou Qianhong Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Changzhou Qianhong Crude Heparin Product Offerings
7.8.5 Changzhou Qianhong Recent Development
7.9 Hepac (Darling Ingredients)
7.9.1 Hepac (Darling Ingredients) Company Information
7.9.2 Hepac (Darling Ingredients) Introduction and Business Overview
7.9.3 Hepac (Darling Ingredients) Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Hepac (Darling Ingredients) Crude Heparin Product Offerings
7.9.5 Hepac (Darling Ingredients) Recent Development
7.10 Huaian MDC Pharmaceutical
7.10.1 Huaian MDC Pharmaceutical Company Information
7.10.2 Huaian MDC Pharmaceutical Introduction and Business Overview
7.10.3 Huaian MDC Pharmaceutical Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Huaian MDC Pharmaceutical Crude Heparin Product Offerings
7.10.5 Huaian MDC Pharmaceutical Recent Development
7.11 Yantai Dongcheng Biochemicals
7.11.1 Yantai Dongcheng Biochemicals Company Information
7.11.2 Yantai Dongcheng Biochemicals Introduction and Business Overview
7.11.3 Yantai Dongcheng Biochemicals Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Yantai Dongcheng Biochemicals Crude Heparin Product Offerings
7.11.5 Yantai Dongcheng Biochemicals Recent Development
8 Industry Chain Analysis
8.1 Crude Heparin Industrial Chain
8.2 Crude Heparin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Crude Heparin Sales Model
8.5.2 Sales Channel
8.5.3 Crude Heparin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Crude Heparin Market Trends
Table 2. Crude Heparin Market Drivers & Opportunity
Table 3. Crude Heparin Market Challenges
Table 4. Crude Heparin Market Restraints
Table 5. Global Crude Heparin Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Crude Heparin Revenue Market Share by Company (2020-2025)
Table 7. Global Crude Heparin Sales Volume by Company (2020-2025) & (Tons)
Table 8. Global Crude Heparin Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Crude Heparin Price by Company (2020-2025) & (US$/Kg)
Table 10. Key Manufacturers Crude Heparin Manufacturing Base and Headquarters
Table 11. Key Manufacturers Crude Heparin Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Crude Heparin
Table 13. Global Crude Heparin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crude Heparin as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Crude Heparin Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Crude Heparin Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Crude Heparin Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Crude Heparin Sales Market Share in Value by Type (2020-2025)
Table 20. Global Crude Heparin Sales Market Share in Value by Type (2026-2031)
Table 21. Global Crude Heparin Sales Volume by Type: 2020 VS 2024 VS 2031 (Tons)
Table 22. Global Crude Heparin Sales Volume by Type (2020-2025) & (Tons)
Table 23. Global Crude Heparin Sales Volume by Type (2026-2031) & (Tons)
Table 24. Global Crude Heparin Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Crude Heparin Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Crude Heparin Price by Type (2020-2025) & (US$/Kg)
Table 27. Global Crude Heparin Price by Type (2026-2031) & (US$/Kg)
Table 28. Global Crude Heparin Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Crude Heparin Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Crude Heparin Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Crude Heparin Sales Market Share in Value by Application (2020-2025)
Table 32. Global Crude Heparin Sales Market Share in Value by Application (2026-2031)
Table 33. Global Crude Heparin Sales Volume by Application: 2020 VS 2024 VS 2031 (Tons)
Table 34. Global Crude Heparin Sales Volume by Application (2020-2025) & (Tons)
Table 35. Global Crude Heparin Sales Volume by Application (2026-2031) & (Tons)
Table 36. Global Crude Heparin Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Crude Heparin Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Crude Heparin Price by Application (2020-2025) & (US$/Kg)
Table 39. Global Crude Heparin Price by Application (2026-2031) & (US$/Kg)
Table 40. Global Crude Heparin Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Crude Heparin Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Crude Heparin Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Crude Heparin Sales Value by Region (2020-2025) & (%)
Table 44. Global Crude Heparin Sales Value by Region (2026-2031) & (%)
Table 45. Global Crude Heparin Sales Volume by Region (Tons): 2020 VS 2024 VS 2031
Table 46. Global Crude Heparin Sales Volume by Region (2020-2025) & (Tons)
Table 47. Global Crude Heparin Sales Volume by Region (2026-2031) & (Tons)
Table 48. Global Crude Heparin Sales Volume by Region (2020-2025) & (%)
Table 49. Global Crude Heparin Sales Volume by Region (2026-2031) & (%)
Table 50. Global Crude Heparin Average Price by Region (2020-2025) & (US$/Kg)
Table 51. Global Crude Heparin Average Price by Region (2026-2031) & (US$/Kg)
Table 52. Key Countries/Regions Crude Heparin Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Crude Heparin Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Crude Heparin Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Crude Heparin Sales Volume, (2020-2025) & (Tons)
Table 56. Key Countries/Regions Crude Heparin Sales Volume, (2026-2031) & (Tons)
Table 57. Bioiberica Company Information
Table 58. Bioiberica Introduction and Business Overview
Table 59. Bioiberica Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 60. Bioiberica Crude Heparin Product Offerings
Table 61. Bioiberica Recent Development
Table 62. Shenzhen Hepalink Company Information
Table 63. Shenzhen Hepalink Introduction and Business Overview
Table 64. Shenzhen Hepalink Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 65. Shenzhen Hepalink Crude Heparin Product Offerings
Table 66. Shenzhen Hepalink Recent Development
Table 67. Sanofi Company Information
Table 68. Sanofi Introduction and Business Overview
Table 69. Sanofi Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 70. Sanofi Crude Heparin Product Offerings
Table 71. Sanofi Recent Development
Table 72. Nanjing King-friend Company Information
Table 73. Nanjing King-friend Introduction and Business Overview
Table 74. Nanjing King-friend Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 75. Nanjing King-friend Crude Heparin Product Offerings
Table 76. Nanjing King-friend Recent Development
Table 77. Fengrun Biological Technology Company Information
Table 78. Fengrun Biological Technology Introduction and Business Overview
Table 79. Fengrun Biological Technology Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 80. Fengrun Biological Technology Crude Heparin Product Offerings
Table 81. Fengrun Biological Technology Recent Development
Table 82. Aspen Oss Company Information
Table 83. Aspen Oss Introduction and Business Overview
Table 84. Aspen Oss Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 85. Aspen Oss Crude Heparin Product Offerings
Table 86. Aspen Oss Recent Development
Table 87. Hebei Changshan Biochemical Company Information
Table 88. Hebei Changshan Biochemical Introduction and Business Overview
Table 89. Hebei Changshan Biochemical Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 90. Hebei Changshan Biochemical Crude Heparin Product Offerings
Table 91. Hebei Changshan Biochemical Recent Development
Table 92. Changzhou Qianhong Company Information
Table 93. Changzhou Qianhong Introduction and Business Overview
Table 94. Changzhou Qianhong Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 95. Changzhou Qianhong Crude Heparin Product Offerings
Table 96. Changzhou Qianhong Recent Development
Table 97. Hepac (Darling Ingredients) Company Information
Table 98. Hepac (Darling Ingredients) Introduction and Business Overview
Table 99. Hepac (Darling Ingredients) Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 100. Hepac (Darling Ingredients) Crude Heparin Product Offerings
Table 101. Hepac (Darling Ingredients) Recent Development
Table 102. Huaian MDC Pharmaceutical Company Information
Table 103. Huaian MDC Pharmaceutical Introduction and Business Overview
Table 104. Huaian MDC Pharmaceutical Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 105. Huaian MDC Pharmaceutical Crude Heparin Product Offerings
Table 106. Huaian MDC Pharmaceutical Recent Development
Table 107. Yantai Dongcheng Biochemicals Company Information
Table 108. Yantai Dongcheng Biochemicals Introduction and Business Overview
Table 109. Yantai Dongcheng Biochemicals Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 110. Yantai Dongcheng Biochemicals Crude Heparin Product Offerings
Table 111. Yantai Dongcheng Biochemicals Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Crude Heparin Downstream Customers
Table 115. Crude Heparin Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Crude Heparin Product Picture
Figure 2. Global Crude Heparin Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Crude Heparin Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Crude Heparin Sales Volume (2020-2031) & (Tons)
Figure 5. Global Crude Heparin Sales Price (2020-2031) & (US$/Kg)
Figure 6. Crude Heparin Report Years Considered
Figure 7. Global Crude Heparin Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Crude Heparin Players Sales Volume Ranking (2024) & (Tons)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Crude Heparin Revenue in 2024
Figure 10. Crude Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Pig Intestine Mucosa Heparin Picture
Figure 12. Bovine Heparin and Others Picture
Figure 13. Global Crude Heparin Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Crude Heparin Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Crude Heparin Sales Volume by Type (2020 VS 2024 VS 2031) & (Tons)
Figure 16. Global Crude Heparin Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Crude Heparin Price by Type (2020-2031) & (US$/Kg)
Figure 18. Product Picture of UFH
Figure 19. Product Picture of LMWH
Figure 20. Global Crude Heparin Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 21. Global Crude Heparin Sales Value Market Share by Application, 2024 & 2031
Figure 22. Global Crude Heparin Sales Volume by Application (2020 VS 2024 VS 2031) & (Tons)
Figure 23. Global Crude Heparin Sales Volume Market Share by Application, 2024 & 2031
Figure 24. Global Crude Heparin Price by Application (2020-2031) & (US$/Kg)
Figure 25. North America Crude Heparin Sales Value (2020-2031) & (US$ Million)
Figure 26. North America Crude Heparin Sales Value by Country (%), 2024 VS 2031
Figure 27. Europe Crude Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 28. Europe Crude Heparin Sales Value by Country (%), 2024 VS 2031
Figure 29. Asia Pacific Crude Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 30. Asia Pacific Crude Heparin Sales Value by Region (%), 2024 VS 2031
Figure 31. South America Crude Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 32. South America Crude Heparin Sales Value by Country (%), 2024 VS 2031
Figure 33. Middle East & Africa Crude Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 34. Middle East & Africa Crude Heparin Sales Value by Country (%), 2024 VS 2031
Figure 35. Key Countries/Regions Crude Heparin Sales Value (%), (2020-2031)
Figure 36. Key Countries/Regions Crude Heparin Sales Volume (%), (2020-2031)
Figure 37. United States Crude Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 38. United States Crude Heparin Sales Value by Type (%), 2024 VS 2031
Figure 39. United States Crude Heparin Sales Value by Application (%), 2024 VS 2031
Figure 40. Europe Crude Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 41. Europe Crude Heparin Sales Value by Type (%), 2024 VS 2031
Figure 42. Europe Crude Heparin Sales Value by Application (%), 2024 VS 2031
Figure 43. China Crude Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 44. China Crude Heparin Sales Value by Type (%), 2024 VS 2031
Figure 45. China Crude Heparin Sales Value by Application (%), 2024 VS 2031
Figure 46. Japan Crude Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 47. Japan Crude Heparin Sales Value by Type (%), 2024 VS 2031
Figure 48. Japan Crude Heparin Sales Value by Application (%), 2024 VS 2031
Figure 49. South Korea Crude Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 50. South Korea Crude Heparin Sales Value by Type (%), 2024 VS 2031
Figure 51. South Korea Crude Heparin Sales Value by Application (%), 2024 VS 2031
Figure 52. Southeast Asia Crude Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 53. Southeast Asia Crude Heparin Sales Value by Type (%), 2024 VS 2031
Figure 54. Southeast Asia Crude Heparin Sales Value by Application (%), 2024 VS 2031
Figure 55. India Crude Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 56. India Crude Heparin Sales Value by Type (%), 2024 VS 2031
Figure 57. India Crude Heparin Sales Value by Application (%), 2024 VS 2031
Figure 58. Crude Heparin Industrial Chain
Figure 59. Crude Heparin Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Related Reports
Global Crude Heparin Market Insights, Forecast to 2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published Date: 2024-04-07
Pages: 108
USD 4900.00
(Single User License)
Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published Date: 2024-04-16
Pages: 147
USD 5900.00
(Single User License)
Global Crude Heparin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published Date: 2024-04-17
Pages: 159
USD 5600.00
(Single User License)
Global Crude Heparin Market Research Report 2025
The global market for Crude Heparin was valued at US$ 3640 million in the year 2024 and is projected to reach a revised size of US$ 5148 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published Date: 2025-01-18
Pages: 88
USD 2900.00
(Single User License)
Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Crude Heparin was estimated to be worth US$ 3640 million and is forecast to reach approximately US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 155
USD 5900.00
(Single User License)
Global Crude Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Crude Heparin market size was US$ 3640 million in 2024 and is forecast to a readjusted size of US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 100
USD 4250.00
(Single User License)
Global Crude Heparin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Crude Heparin market is projected to grow from US$ 3640 million in 2024 to US$ 5148 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-10
Pages: 164
USD 4900.00
(Single User License)
Crude Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Crude Heparin was estimated to be worth US$ 3809 million in 2025 and is projected to reach US$ 5387 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 112
USD 3950.00
(Single User License)
Global Crude Heparin Market Research Report 2026
The global Crude Heparin market was valued at US$ 3809 million in 2025 and is anticipated to reach US$ 5387 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 124
USD 2900.00
(Single User License)
Global Crude Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Crude Heparin market size was US$ 3809 million in 2025 and is forecast to reach a readjusted size of US$ 5387 million by 2032 with a CAGR of 5.1% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 95
USD 4250.00
(Single User License)
Global Crude Heparin Market Insights, Forecast to 2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published: 2024-04-07
Pages: 108
USD 4900.00 (Single User License)Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published: 2024-04-16
Pages: 147
USD 5900.00 (Single User License)Global Crude Heparin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published: 2024-04-17
Pages: 159
USD 5600.00 (Single User License)Global Crude Heparin Market Research Report 2025
The global market for Crude Heparin was valued at US$ 3640 million in the year 2024 and is projected to reach a revised size of US$ 5148 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published: 2025-01-18
Pages: 88
USD 2900.00 (Single User License)Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Crude Heparin was estimated to be worth US$ 3640 million and is forecast to reach approximately US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 155
USD 5900.00 (Single User License)Global Crude Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Crude Heparin market size was US$ 3640 million in 2024 and is forecast to a readjusted size of US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 100
USD 4250.00 (Single User License)Global Crude Heparin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Crude Heparin market is projected to grow from US$ 3640 million in 2024 to US$ 5148 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-10
Pages: 164
USD 4900.00 (Single User License)Crude Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Crude Heparin was estimated to be worth US$ 3809 million in 2025 and is projected to reach US$ 5387 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 112
USD 3950.00 (Single User License)Global Crude Heparin Market Research Report 2026
The global Crude Heparin market was valued at US$ 3809 million in 2025 and is anticipated to reach US$ 5387 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 124
USD 2900.00 (Single User License)Global Crude Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Crude Heparin market size was US$ 3809 million in 2025 and is forecast to reach a readjusted size of US$ 5387 million by 2032 with a CAGR of 5.1% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 95
USD 4250.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Market Segmentation
QYResearch's Strengths
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research